These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

592 related items for PubMed ID: 36155321

  • 1. White matter hyperintensity distribution differences in aging and neurodegenerative disease cohorts.
    Dadar M, Mahmoud S, Zhernovaia M, Camicioli R, Maranzano J, Duchesne S, CCNA Group.
    Neuroimage Clin; 2022; 36():103204. PubMed ID: 36155321
    [Abstract] [Full Text] [Related]

  • 2. White matter hyperintensities are associated with grey matter atrophy and cognitive decline in Alzheimer's disease and frontotemporal dementia.
    Dadar M, Manera AL, Ducharme S, Collins DL.
    Neurobiol Aging; 2022 Mar; 111():54-63. PubMed ID: 34968832
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cerebrovascular lesion loads and accelerated brain aging: insights into the cognitive spectrum.
    Beheshti I, Potvin O, Dadar M, Duchesne S.
    Front Dement; 2024 Mar; 3():1380015. PubMed ID: 39081605
    [Abstract] [Full Text] [Related]

  • 5. Vascular Contributions to Neurodegeneration: Protocol of the COMPASS-ND Study.
    Smith EE, Duchesne S, Gao F, Saad F, Whitehead V, McCreary CR, Frayne R, Gauthier S, Camicioli R, Borrie M, Black SE.
    Can J Neurol Sci; 2021 Nov; 48(6):799-806. PubMed ID: 33504400
    [Abstract] [Full Text] [Related]

  • 6. Regional White Matter Hyperintensities and Alzheimer's Disease Biomarkers Among Older Adults with Normal Cognition and Mild Cognitive Impairment.
    Newton P, Tchounguen J, Pettigrew C, Lim C, Lin Z, Lu H, Moghekar A, Albert M, Soldan A, BIOCARD Research Team.
    J Alzheimers Dis; 2023 Nov; 92(1):323-339. PubMed ID: 36744337
    [Abstract] [Full Text] [Related]

  • 7. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease.
    Sunwoo MK, Jeon S, Ham JH, Hong JY, Lee JE, Lee JM, Sohn YH, Lee PH.
    Eur J Neurol; 2014 Jun; 21(6):922-e50. PubMed ID: 24661277
    [Abstract] [Full Text] [Related]

  • 8. Brain amyloid and vascular risk are related to distinct white matter hyperintensity patterns.
    Pålhaugen L, Sudre CH, Tecelao S, Nakling A, Almdahl IS, Kalheim LF, Cardoso MJ, Johnsen SH, Rongve A, Aarsland D, Bjørnerud A, Selnes P, Fladby T.
    J Cereb Blood Flow Metab; 2021 May; 41(5):1162-1174. PubMed ID: 32955960
    [Abstract] [Full Text] [Related]

  • 9. White Matter Hyperintensities and Mild Cognitive Impairment in Parkinson's Disease.
    Mak E, Dwyer MG, Ramasamy DP, Au WL, Tan LC, Zivadinov R, Kandiah N.
    J Neuroimaging; 2015 May; 25(5):754-60. PubMed ID: 25753576
    [Abstract] [Full Text] [Related]

  • 10. Association of Regional White Matter Hyperintensities With Longitudinal Alzheimer-Like Pattern of Neurodegeneration in Older Adults.
    Rizvi B, Lao PJ, Chesebro AG, Dworkin JD, Amarante E, Beato JM, Gutierrez J, Zahodne LB, Schupf N, Manly JJ, Mayeux R, Brickman AM.
    JAMA Netw Open; 2021 Oct 01; 4(10):e2125166. PubMed ID: 34609497
    [Abstract] [Full Text] [Related]

  • 11. White matter hyperintensities are not associated with cognitive decline in early Parkinson's disease - The DeNoPa cohort.
    Hanning U, Teuber A, Lang E, Trenkwalder C, Mollenhauer B, Minnerup H.
    Parkinsonism Relat Disord; 2019 Dec 01; 69():61-67. PubMed ID: 31678722
    [Abstract] [Full Text] [Related]

  • 12. White matter hyperintensity burden predicts cognitive but not motor decline in Parkinson's disease: results from the Ontario Neurodegenerative Diseases Research Initiative.
    Carvalho de Abreu DC, Pieruccini-Faria F, Sarquis-Adamson Y, Black A, Fraser J, Van Ooteghem K, Cornish B, Grimes D, Jog M, Masellis M, Steeves T, Nanayakkara N, Ramirez J, Scott C, Holmes M, Ozzoude M, Berezuk C, Symons S, Mohammad Hassan Haddad S, Arnott SR, Binns M, Strother S, Beaton D, Sunderland K, Theyers A, Tan B, Zamyadi M, Levine B, Orange JB, Roberts AC, Lou W, Sujanthan S, Breen DP, Marras C, Kwan D, Adamo S, Peltsch A, Troyer AK, Black SE, McLaughlin PM, Lang AE, McIlroy W, Bartha R, ONDRI Investigators, Montero-Odasso M.
    Eur J Neurol; 2023 Apr 01; 30(4):920-933. PubMed ID: 36692250
    [Abstract] [Full Text] [Related]

  • 13. White matter hyperintensity patterns: associations with comorbidities, amyloid, and cognition.
    Bachmann D, von Rickenbach B, Buchmann A, Hüllner M, Zuber I, Studer S, Saake A, Rauen K, Gruber E, Nitsch RM, Hock C, Treyer V, Gietl A.
    Alzheimers Res Ther; 2024 Apr 01; 16(1):67. PubMed ID: 38561806
    [Abstract] [Full Text] [Related]

  • 14. White matter hyperintensities in progranulin-associated frontotemporal dementia: A longitudinal GENFI study.
    Sudre CH, Bocchetta M, Heller C, Convery R, Neason M, Moore KM, Cash DM, Thomas DL, Woollacott IOC, Foiani M, Heslegrave A, Shafei R, Greaves C, van Swieten J, Moreno F, Sanchez-Valle R, Borroni B, Laforce R, Masellis M, Tartaglia MC, Graff C, Galimberti D, Rowe JB, Finger E, Synofzik M, Vandenberghe R, de Mendonça A, Tagliavini F, Santana I, Ducharme S, Butler C, Gerhard A, Levin J, Danek A, Frisoni GB, Sorbi S, Otto M, Zetterberg H, Ourselin S, Cardoso MJ, Rohrer JD, On behalf of, GENFI.
    Neuroimage Clin; 2019 Apr 01; 24():102077. PubMed ID: 31835286
    [Abstract] [Full Text] [Related]

  • 15. Association between brain amyloid deposition and longitudinal changes of white matter hyperintensities.
    Cha WJ, Yi D, Ahn H, Byun MS, Chang YY, Choi JM, Kim K, Choi H, Jung G, Kang KM, Sohn CH, Lee YS, Kim YK, Lee DY.
    Alzheimers Res Ther; 2024 Mar 07; 16(1):50. PubMed ID: 38454444
    [Abstract] [Full Text] [Related]

  • 16. White matter hyperintensities are linked to future cognitive decline in de novo Parkinson's disease patients.
    Dadar M, Zeighami Y, Yau Y, Fereshtehnejad SM, Maranzano J, Postuma RB, Dagher A, Collins DL.
    Neuroimage Clin; 2018 Mar 07; 20():892-900. PubMed ID: 30292088
    [Abstract] [Full Text] [Related]

  • 17. White Matter Hyperintensities and Cognitive Impairment in Healthy and Pathological Aging: A Quantified Brain MRI Study.
    Kaskikallio A, Karrasch M, Koikkalainen J, Lötjönen J, Rinne JO, Tuokkola T, Parkkola R, Grönholm-Nyman P.
    Dement Geriatr Cogn Disord; 2019 Mar 07; 48(5-6):297-307. PubMed ID: 32209796
    [Abstract] [Full Text] [Related]

  • 18. Topographical differences in white matter hyperintensity burden and cognition in aging, MCI, and AD.
    Kamal F, Morrison C, Maranzano J, Zeighami Y, Dadar M.
    Geroscience; 2023 Feb 07; 45(1):1-16. PubMed ID: 36229760
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.